Key points are not available for this paper at this time.
Based on high-quality data from European national registries, IgAN point prevalence was estimated at 2.53 per 10 000 in patients of all ages. Prevalence was considerably lower in pediatric and elderly populations.
Willey et al. (Mon,) studied this question.